GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Axsome Therapeutics Inc (FRA:19X) » Definitions » E10

Axsome Therapeutics (FRA:19X) E10 : €-2.59 (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Axsome Therapeutics E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Axsome Therapeutics's adjusted earnings per share data for the three months ended in Mar. 2024 was €-1.325. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-2.59 for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-06-01), Axsome Therapeutics's current stock price is €67.72. Axsome Therapeutics's E10 for the quarter that ended in Mar. 2024 was €-2.59. Axsome Therapeutics's Shiller PE Ratio of today is .


Axsome Therapeutics E10 Historical Data

The historical data trend for Axsome Therapeutics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Axsome Therapeutics E10 Chart

Axsome Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -2.40

Axsome Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -2.40 -2.59

Competitive Comparison of Axsome Therapeutics's E10

For the Biotechnology subindustry, Axsome Therapeutics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Axsome Therapeutics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Axsome Therapeutics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Axsome Therapeutics's Shiller PE Ratio falls into.



Axsome Therapeutics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Axsome Therapeutics's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-1.325/131.7762*131.7762
=-1.325

Current CPI (Mar. 2024) = 131.7762.

Axsome Therapeutics Quarterly Data

per share eps CPI Adj_EPS
201406 0.000 100.560 0.000
201409 -0.015 100.428 -0.020
201412 -0.095 99.070 -0.126
201503 -0.155 99.621 -0.205
201506 -0.149 100.684 -0.195
201509 -0.230 100.392 -0.302
201512 -0.110 99.792 -0.145
201603 -0.278 100.470 -0.365
201606 -0.320 101.688 -0.415
201609 -0.339 101.861 -0.439
201612 -0.360 101.863 -0.466
201703 -0.383 102.862 -0.491
201706 -0.267 103.349 -0.340
201709 -0.227 104.136 -0.287
201712 -0.262 104.011 -0.332
201803 -0.154 105.290 -0.193
201806 -0.274 106.317 -0.340
201809 -0.266 106.507 -0.329
201812 -0.281 105.998 -0.349
201903 -0.283 107.251 -0.348
201906 -0.363 108.070 -0.443
201909 -0.508 108.329 -0.618
201912 -0.639 108.420 -0.777
202003 -0.796 108.902 -0.963
202006 -0.435 108.767 -0.527
202009 -0.518 109.815 -0.622
202012 -0.641 109.897 -0.769
202103 -0.655 111.754 -0.772
202106 -0.714 114.631 -0.821
202109 -0.791 115.734 -0.901
202112 -0.797 117.630 -0.893
202203 -0.935 121.301 -1.016
202206 -1.003 125.017 -1.057
202209 -1.081 125.227 -1.138
202212 -1.331 125.222 -1.401
202303 -0.243 127.348 -0.251
202306 -1.421 128.729 -1.455
202309 -1.237 129.860 -1.255
202312 -1.907 129.419 -1.942
202403 -1.325 131.776 -1.325

Add all the adjusted EPS together and divide 10 will get our e10.


Axsome Therapeutics  (FRA:19X) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Axsome Therapeutics E10 Related Terms

Thank you for viewing the detailed overview of Axsome Therapeutics's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Axsome Therapeutics (FRA:19X) Business Description

Traded in Other Exchanges
Address
22 Cortlandt Street, 16th Floor, New York, NY, USA, 10007
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14.

Axsome Therapeutics (FRA:19X) Headlines

No Headlines